Expression of PPARgamma and beta/delta in human primary osteoblastic cells: influence of polyunsaturated fatty acids.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Calcified Tissue International

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 15868283
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rosiglitazone impacts negatively on bone by promoting osteoblast/osteocyte apoptosis.

  2004cited by this paper
• Fat's loss is bone's gain.

  2004cited by this paper
• Bone is a target for the antidiabetic compound rosiglitazone.

  2004cited by this paper
• Peroxisome Proliferator-Activated Receptor Ligands Affect Growth-Related Gene Expression in Human Leukemic Cells

  2003cited by this paper
• Activation of Peroxisome Proliferator-activated Receptor-γ Inhibits the Runx2-mediated Transcription of Osteocalcin in Osteoblasts*

  2003cited by this paper
• Activation of peroxisome proliferator-activated receptor-gamma inhibits differentiation of preosteoblasts.

  2003cited by this paper
• Adipogenesis and aging: does aging make fat go MAD?

  2002cited by this paper
• PPARs: transcriptional effectors of fatty acids and their derivatives

  2002cited by this paper
• Dietary polyunsaturated fatty acids and regulation of gene transcription

  2002cited by this paper
• Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation.

  2002cited by this paper
• Peroxisome proliferator-activated receptor delta is up-regulated during vascular lesion formation and promotes post-confluent cell proliferation in vascular smooth muscle cells.

  2002cited by this paper
• Role of polyunsaturated fatty acids in the inhibitory effect of human adipocytes on osteoblastic proliferation.

  2002cited by this paper
• Protein Kinase Inhibition by ω-3 Fatty Acids*

  2001cited by this paper
• Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1.

  2001cited by this paper
• PPARgamma : a nuclear regulator of metabolism, differentiation, and cell growth.

  2001cited by this paper
• The roles of PPARs in adipocyte differentiation.

  2001cited by this paper
• Influence of mature adipocytes on osteoblast proliferation in human primary cocultures.

  2000cited by this paper
• Transcriptional regulation of adipogenesis.

  2000cited by this paper
• 15-Deoxy-Delta(12,14)-prostaglandin J(2) induces G(1) arrest and differentiation marker expression in vascular smooth muscle cells.

  2000cited by this paper
• Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1--> S transition in vascular smooth muscle cells.

  2000cited by this paper
• Fatty Acid Regulation of Gene Transcription*

  2000cited by this paper
• Cloning and expression of human TRAAK, a polyunsaturated fatty acids‐activated and mechano‐sensitive K+ channel

  2000cited by this paper
• Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARγ2

  1999cited by this paper
• Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes.

  1999cited by this paper
• Multilineage potential of adult human mesenchymal stem cells.

  1999cited by this paper
• Expression of Peroxisome Proliferator-activated Receptor PPARδ Promotes Induction of PPARγ and Adipocyte Differentiation in 3T3C2 Fibroblasts*

  1999cited by this paper
• High Fatty Acid Content in Rabbit Serum Is Responsible for the Differentiation of Osteoblasts Into Adipocyte‐like Cells

  1998cited by this paper
• Human Trabecular Bone Cells Are Able to Express Both Osteoblastic and Adipocytic Phenotype: Implications for Osteopenic Disorders

  1998cited by this paper
• Functional Modulation of Human Recombinant γ-Aminobutyric Acid Type A Receptor by Docosahexaenoic Acid*

  1998cited by this paper
• Peroxisome proliferator activated receptor gamma, CCAAT/enhancer-binding protein alpha, and cell cycle status regulate the commitment to adipocyte differentiation.

  1997cited by this paper
• 19th Annual meeting of the American Society for Bone and Mineral Research. Cincinnati, Ohio, September 10-14, 1997. Abstracts.

  1997cited by this paper
• Regulating Adipogenesis*

  1997cited by this paper
• PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A.

  1997cited by this paper
• Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells.

  1996cited by this paper
• Activation of gene transcription by prostacyclin analogues is mediated by the peroxisome-proliferators-activated receptor (PPAR).

  1996cited by this paper
• The cellular protooncogenes c-fos and egr-1 are regulated by prostacyclin in rodent osteoblasts and fibroblasts.

  1996cited by this paper
• Thiazolidinediones and Fatty Acids Convert Myogenic Cells into Adipose-like Cells (*)

  1995cited by this paper
• Differential Activation of Peroxisome Proliferator-activated Receptors by Eicosanoids (*)

  1995cited by this paper
• A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation.

  1995cited by this paper
• 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma.

  1995cited by this paper
• Fatty acids and cell signal transduction.

  1994cited by this paper
• Interactions of long-chain fatty acids and albumin: determination of free fatty acid levels using the fluorescent probe ADIFAB.

  1993cited by this paper
• Docosahexaenoic acid increases permeability of lipid vesicles and tumor cells

  1993cited by this paper
• Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids.

  1992cited by this paper
• Influence of experimental conditions on osteoblast activity in human primary bone cell cultures

  1990cited by this paper
• Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis.

  1983cited by this paper
• Clonal preadipocyte cell lines with different phenotypes derived from murine marrow stroma: Factors influencing growth and Adipogenesis in vitro

  1982cited by this paper
• Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies.

  1971cited by this paper

• In vivo CRISPR activation screen identifies acyl-CoA-binding protein as a driver of bone metastasis.

  2025cites this paper
• Polyunsaturated Fatty Acids Level and Bone Mineral Density: A Two-Sample Mendelian Randomization Study

  2022cites this paper
• Alterations in bone metabolites with age in C57BL/6 mice model

  2022cites this paper
• Omega-9 Modifies Viscoelasticity and Augments Bone Strength and Architecture in a High-Fat Diet-Fed Murine Model

  2022cites this paper
• Integration of Proteomics and Metabonomics in Exploring the Protecting Mechanism of Gushukang Capsule in Osteoporosis Rats

  2021cites this paper
• Adverse plasma fatty acid composition in patients with femoral neck fracture.

  2020cites this paper
• Effects of telmisartan and losartan treatments on bone turnover markers in patients with newly diagnosed stage I hypertension

  2019cites this paper
• Arachidonic acid exacerbates diet-induced obesity and reduces bone mineral content without impacting bone strength in growing male rats.

  2019cites this paper
• The Relationship Between Omega-3, Omega-6 and Total Polyunsaturated Fat and Musculoskeletal Health and Functional Status in Adults: A Systematic Review and Meta-analysis of RCTs

  2019cites this paper
• Mammalian target of rapamycin as a therapeutic target in osteoporosis

  2018cites this paper
• Bone marrow Fat - A Novel Quantification Method and Potential Clinical Applications

  2017cites this paper
• GPR40 mediates potential positive effects of a saturated fatty acid enriched diet on bone

  2017cites this paper
• Unsaturation level decreased in bone marrow fat of postmenopausal women with low bone density using high resolution magic angle spinning (HRMAS) 1H NMR spectroscopy.

  2017cites this paper
• Intake of omega-3 fatty acids contributes to bone mineral density at the hip in a younger Japanese female population

  2017cites this paper
• Diabetes and Bone Marrow Adiposity

  2016cites this paper
• In Vitro Effects of Pioglitazone on the Expression of Components of Wnt Signaling Pathway and Markers of Bone Mineralization

  2016cites this paper
• 17-β-estradiol up-regulates apolipoprotein genes expression during osteoblast differentiation in vitro.

  2016cites this paper
• PUFAs, Bone Mineral Density, and Fragility Fracture: Findings from Human Studies.

  2016cites this paper
• Pros and cons of fatty acids in bone biology.

  2015cites this paper
• GPR40, a free fatty acid receptor, differentially impacts osteoblast behavior depending on differentiation stage and environment

  2015cites this paper
• The role of albumin and PPAR‐α in differentiation‐dependent change of fatty acid profile during differentiation of mesenchymal stem cells to hepatocyte‐like cells

  2014cites this paper
• Retinaldehyde dehydrogenase 1 deficiency inhibits PPARγ-mediated bone loss and marrow adiposity.

  2014cites this paper
• Effect of retinoic acid and vitamin D3 on osteoblast differentiation and activity in aging

  2014cites this paper
• Regulation of selective PPARγ modulators in the differentiation of osteoclasts

  2013cites this paper
• Marrow fat and bone--new perspectives.

  2013cites this paper
• The omega-6 arachidonic fatty acid, but not the omega-3 fatty acids, inhibits osteoblastogenesis and induces adipogenesis of human mesenchymal stem cells: potential implication in osteoporosis

  2013cites this paper
• Osteoblast‐Targeted suppression of PPARγ increases osteogenesis through activation of mTOR signaling

  2013cites this paper
• Polyunsaturated Fatty Acids and Their Relation with Bone and Muscle Health in Adults

  2013cites this paper
• Serotonin 2B Receptor (5-HT2B R) Signals through Prostacyclin and PPAR-ß/δ in Osteoblasts

  2013cites this paper
• The Free Fatty Acid Receptor G Protein-coupled Receptor 40 (GPR40) Protects from Bone Loss through Inhibition of Osteoclast Differentiation*

  2013cites this paper
• 3D micropatternable hydrogel systems to examine crosstalk effects between mesenchymal stem cells, osteoblasts, and adipocytes

  2012influential citation
• The role of apolipoprotein E in bone metabolism.

  2012cites this paper
• Impact of conjugated linoleic acid on bone physiology: proposed mechanism involving inhibition of adipogenesis.

  2011cites this paper
• The Oncofetal Gene Survivin Promotes Cell Proliferation and Survival in Primary Human Osteoblastic Cells

  2011cites this paper
• Effects of DP and CRTH2 activation on osteoblast function

  2011cites this paper
• A Subset of Osteoblasts Expressing High Endogenous Levels of PPARγ Switches Fate to Adipocytes in the Rat Calvaria Cell Culture Model

  2010cites this paper
• Long-chain polyunsaturated fatty acids: selected mechanisms of action on bone.

  2010cites this paper
• Uptake of postprandial lipoproteins into bone in vivo: impact on osteoblast function.

  2008cites this paper
• PPARδ Agonism for the Treatment of Obesity and Associated Disorders: Challenges and Opportunities

  2008cites this paper
• The roles of prostanoids, leukotrienes, and platelet-activating factor in bone metabolism and disease.

  2008cites this paper
• Nuclear receptor profile in calvarial bone cells undergoing osteogenic versus adipogenic differentiation

  2008cites this paper
• Long-Chain Polyunsaturated Fatty Acids and the Regulation of Bone Metabolism

  2007cites this paper
• Peroxisome proliferator-activated receptor-γ ligands as bone turnover modulators

  2007cites this paper
• Prolyl‐hydroxylase inhibition and HIF activation in osteoblasts promotes an adipocytic phenotype

  2007cites this paper
• Peroxisome proliferator‐activated receptors (PPARs) in the control of bone metabolism

  2007cites this paper
• Activation of PPARδ inhibits cardiac fibroblast proliferation and the transdifferentiation into myofibroblasts

  2007cites this paper